Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPAL-1: KB707 in Advanced Solid Tumors and Melanoma
NCT05970497Phase 2Recruiting
- Sponsor
- Krystal Biotech, Inc.
- Start
- Oct 2023
- Primary completion
- Jul 2027
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of KB707 in solid tumor, melanoma, sponsored by Krystal Biotech, Inc.. Started Oct 2023; status: recruiting.
02
Drugs
KB707
03
Conditions
solid tumormelanoma
Beyond the preview
Go deeper on NCT05970497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970497.